Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Najafi
Observed names:
Najafi, Sara,
S Najafi
Institutions:
Mashhad University of Medical Sciences,
German Cancer Research Center,
National Center for Tumor Diseases,
Hopp Children's Cancer Center Heidelberg,
Deutsches Konsortium für Translationale Krebsforschung
Observed institutions:
Mashhad University of Medical Sciences,
German Cancer Research Center,
Heidelberg University,
University Hospital Heidelberg,
National Center for Tumor Diseases,
Hopp Children's Cancer Center Heidelberg,
Deutsches Konsortium für Translationale Krebsforschung
show all 7
ORCID:
0000-0003-1218-1817
Observed ORCID:
0000-0003-1218-1817
OpenAlex ID:
A5076344546
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models
2022
·
Romain Sigaud
, Lisa Rösch
, et al.
·
Neuro-Oncology
·
55
A randomized, double‐blind , placebo‐controlled , clinical trial to evaluate the benefits of Nigella sativa seeds oil in reducing cardiovascular risks in hypertensive patients
2021
·
Parisa Shoaei‐Hagh
, Farzaneh Kamelan Kafi
, et al.
·
Phytotherapy Research
·
46
The effect of glucagon‐like peptide‐1 receptor agonists on serum uric acid concentration: A systematic review and meta‐analysis
2022
·
Sara Najafi
, Milad Bahrami
, et al.
·
British Journal of Clinical Pharmacology
·
43
PDF
Administration of Silver Nanoparticles in Diabetes Mellitus: A Systematic Review and Meta-analysis on Animal Studies
2021
·
Farnaz Torabian
, Arash Akhavan Rezayat
, et al.
·
Biological Trace Element Research
·
39
Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma
2021
·
Katharina Körholz
, Johannes Ridinger
, et al.
·
Cells
·
36
PDF
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models
2022
·
Charlotte Gatzweiler
, Johannes Ridinger
, et al.
·
Cancers
·
34
PDF
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
2020
·
Jagoda K Wrobel
, Sara Najafi
, et al.
·
Pharmaceuticals
·
30
PDF
A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment
2018
·
Jing Shen
, Sara Najafi
, et al.
·
Cell Death and Differentiation
·
30
PDF
Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins
2024
·
Melisa Halilovic
, Mohamed Abdelsalam
, et al.
·
Leukemia
·
29
PDF
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma
2021
·
Michael Müller
, Lisa Rösch
, et al.
·
Cancers
·
14
PDF
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells
2025
·
Andreas O. Mieland
, Giuseppe Petrosino
, et al.
·
Leukemia
·
13
PDF
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours
2024
·
Till Seiboldt
, Constantia Zeiser
, et al.
·
British Journal of Cancer
·
11
PDF
ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein
2022
·
Lisa Rösch
, Sonja Herter
, et al.
·
Molecular Oncology
·
10
PDF
Identification of a Proteolysis‐Targeting‐Chimera that Addresses Activated Checkpoint Kinase‐1 Reveals its Non‐Catalytic Functions in Tumor Cells
2025
·
Ramy Ashry
, Mohamed Abdelsalam
, et al.
·
Angewandte Chemie International Edition
·
5
PDF
Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model
2022
·
Charlotte Gatzweiler
, Johannes Ridinger
, et al.
·
Methods in molecular biology
·
5
Mortality risk factors in kidney‐transplanted patients with COVID ‐19: A systematic review and regression analysis
2021
·
Yasaman Navari
, Amir Behzad Bagheri
, et al.
·
Health Science Reports
·
5
PDF
A meta-analytic evaluation of the efficacy and safety of levetiracetam for treating myoclonic seizures
2025
·
Sara Najafi
, Mohaddeseh Sadat Alavi
, et al.
·
Heliyon
·
3
Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11
2024
·
Vid Mlakar
, Ina Oehme
, et al.
·
Frontiers in Oncology
·
2
PDF
A Bizarre Case of Anaphylaxis due to Hydatid Cyst Perforation Presented as Respiratory Arrest: A Case Report
2021
·
Sajjad Saghebdoust
, Elham Nikrouh
, et al.
·
International journal of pediatrics
·
2
Rapid proteasomal degradation of mutant feline McDonough sarcoma-like tyrosine kinase-3 overcomes tyrosine kinase inhibitor resistance of acute myeloid leukemia cells
2025
·
Melisa Halilovic
, Mohamed Abdelsalam
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Rapid proteasomal degradation of mutant feline McDonough sarcoma-like tyrosine kinase-3 overcomes inhibitor resistance mechanisms of acute myeloid leukemia cells
2026
·
Melisa Halilovic
, Mohamed Abdelsalam
, et al.
·
Leukemia
PDF
Ethosuximide-induced lupus erythematosus: Unveiling a rare adverse reaction through systematic review
2026
·
Sara Najafi
, Mohaddeseh Sadat Alavi
, et al.
·
Epilepsy & Behavior Reports
PDF
Identifizierung eines Moleküls, das den Abbau der aktivierten Checkpoint‐Kinase‐1 auslöst und Charakterisierung der nicht‐katalytischen Funktionen von Checkpoint‐Kinase‐1 in Tumorzellen
2025
·
Ramy Ashry
, Mohamed Abdelsalam
, et al.
·
Angewandte Chemie
Abstract 5221: The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitors or senolytics
2022
·
Romain Sigaud
, Lisa Rösch
, et al.
·
Cancer Research
LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitors or senolytics
2022
·
Romain Sigaud
, Lisa Rösch
, et al.
·
Neuro-Oncology
PDF
Show more works
View as search
Works count:
28
Citation count:
410
H-index:
11
I10-index:
13
Year
Topic
Type